Increased expression of major histocompatibility complex (MHC) class I genes and aberrant expression of MHC class II genes in thyroid epithelial cells (TEC) is associated with autoimmune thyroid diseases. Previous studies have shown that methimazole (MMI) reduces MHC class I expression and inhibits the interferon- (IFN-)-induced expression of MHC class II gene in TEC. The action of MMI on MHC class I gene is transcriptional but its mechanism has not been previously investigated. In this report we show that using FRTL-5 cells, the ability of MMI and its novel derivative phenylmethimazole (C10), to decrease MHC class I promoter activity, is similar to the TSH/cAMP suppression of the MHC class I and TSH receptor genes and involves a 39 bp silencer containing a CRE-like site. Furthermore, we show that C10 decreases MHC class I gene expression to a greater extent than MMI and at a 10-50 fold lower concentration. C10 also reduces the ability of IFN-to increase the expression of MHC class I and MHC class II genes more effectively than MMI,. Finally, we show that C10 is a better inhibitor than MMI of specific protein-DNA complexes formed with a CRE-like element on the MHC class II promoter. These data support the conclusion that the immunosuppressive mechanism by which MMI and C10 inhibit MHC gene expression mimics normal hormonal suppression by TSH/cAMP.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC009285-23
Application #
7965158
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
23
Fiscal Year
2009
Total Cost
$308,664
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Devaiah, Ballachanda N; Case-Borden, Chanelle; Gegonne, Anne et al. (2016) BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin. Nat Struct Mol Biol 23:540-8
Roy, Ananda L; Singer, Dinah S (2015) Core promoters in transcription: old problem, new insights. Trends Biochem Sci 40:165-71
Soe, Katherine C; Devaiah, Ballachanda N; Singer, Dinah S (2013) Transcriptional coactivator CIITA, a functional homolog of TAF1, has kinase activity. Biochim Biophys Acta 1829:1184-90
Devaiah, Ballachanda N; Singer, Dinah S (2013) CIITA and Its Dual Roles in MHC Gene Transcription. Front Immunol 4:476
Lee, Namhoon; Iyer, Shankar S; Mu, Jie et al. (2010) Three novel downstream promoter elements regulate MHC class I promoter activity in mammalian cells. PLoS One 5:e15278
Devaiah, Ballachanda N; Lu, Hanxin; Gegonne, Anne et al. (2010) Novel functions for TAF7, a regulator of TAF1-independent transcription. J Biol Chem 285:38772-80
Charni, Seyma; Aguilo, Juan Ignacio; Garaude, Johan et al. (2009) ERK5 knockdown generates mouse leukemia cells with low MHC class I levels that activate NK cells and block tumorigenesis. J Immunol 182:3398-405